еНаука - преглед
Преглед према Аутор Barrett, Martin
Приказ резултата 1 до 5 од 5
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2017 | Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial | Davies, Andrew; Merli, Francesco; Mihaljevic, Biljana S  ; Mercadal, Santiago; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; Genevray, Magali; Zharkov, Artem;
Dixon, Mark; Brewster, Michael; Barrett, Martin; MacDonald, David;
| Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2016 | Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study | Davies, Andrew J; Mihaljevic, Biljana S ; Mercadal, Santiago; Mihaylov, Georgi; Leppa, Sirpa; Cotting, Denise; Veenstra, Klaas; Zharkov, Artem; Dixon, Mark; Barrett, Martin;
Macdonald, David;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2012 | Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follic | Davies, Andrew J; Merli, Francesco; Mihaljevic, Biljana S ; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; McIntyre, Christine; Barrett, Martin; Macdonald, David | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2014 | Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study | Davies, Andrew; Merli, Francesco; Mihaljević, Biljana ; Siritanaratkul, Noppadol; Solal-Céligny, Phillippe; Barrett, Martin; Berge, Claude; Bittner, Beate; Boehnke, Axel; McIntyre, Christine;
MacDonald, David;
| Научни чланак | 21a+M21a+ - Водећи међународни часопис категорије M21a+ |
| 2013 | Subcutaneous Rituximab and Chemotherapy Achieves Similar Trough Levels, Safety, and Response as Intravenous Rituximab in First-Line Follicular Lymphoma: Stage 1 Results of the Phase 3 Sabrina Study | Davies, Andrew; Merli, Francesco; Mihaljevic, Biljana S ; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; McIntyre, Christine; Barrett, Martin; Macdonald, David | Конференцијски рад | Мп категорија ће бити приказана накнадно. |